The Rokslide Stock Traders Thread

[Ckat]

I did. Might be trying to catch a falling knife. . Most price targets are positive. Google owns 6% of the company. Ceo of Frsh just bought 125,000 shares. Blackrock and Vanguard own more than that. Small stake on my part, that might be worth the gamble, might turn out to be a dud.

Don’t let @Beendare be a Debbie Downer with charts, financials, and other research… go big or go home!

I actually appreciate and lean on beendare’s conservatism and strategic thinking… it has made me stop and analyze multiple times, instead of making knee-jerk decisions of, “Oh, this has got to be good!!!”

I love this thread and the thought-provoking insight it provides…

 

[IdahoBeav]

MU hit $650 today

 

[LFC911]

MU hit $650 today

Shoulda kept it lol hindsight is 20/20

 

[Beendare]

Don’t let @Beendare be a Debbie Downer with charts, financials, and other research… go big or go home!

I actually appreciate and lean on beendare’s conservatism and strategic thinking… it has made me stop and analyze multiple times, instead of making knee-jerk decisions of, “Oh, this has got to be good!!!”

I love this thread and the thought-provoking insight it provides…

I like seeing those ideas too....and I only did a cursory look at FRSH so don't go by my opinion. @HuntHarder could be onto something with those outfits taking stakes in the company....heck, I don't know.
I do know that an outfit like GOOG can throw funny money at a company -just like a roulette wheel- as with their excess profit they have their own hedge fund arm. (GOOG owns a big chunk of Anthropic- Licking lips here)

I have friends that are financial planners...and along with the guy at Schwab listed on my account (that doesn't do a thing for me) they all comment I'm taking on too much risk by having single stocks in the tech sector and they are a high % of my account. I hold my tongue but feel like saying, "Yeah, its becuase they are up 100% to 300% plus in the last few years"

Now if a family relies on those investments to live off of or its a n essential need for retirement, then the strategy to prune those winners to a manageable size might be the way to go. .

My sector focus has done very well for me over the years though it's volatile. [Have you seen MU lately- sheesh, up 7%, then down 4% the next day)

Those tech picks have huge sales and gross profits as much as 60%. As long as they are still making huge profits and have high demand for their products, I ride that train though it's bumpy for sure. I figure that if they drop 20%, I'm still up way over what it would have been playing it safe.

Now here with this crowd....I look too conservative....go figure, grin.

 

[HuntHarder]

Like any stock pick I see on here, do your own due diligence. Understand that all of us are at different points in our lives with different tolerances for risk. I appreciate all views on here.

I have my core investments that have done me well over the years. I also enjoy gambling, I mean single stock picking. . My stake in smaller company, single stock picks, are small in nature. Some of them have turned into some of my largest positions. Simply DCA over time.

 

[Jakeb]

I figured sndk was about topped out around 700 in March. Now I’m debating buying some at 1400.

 

[MuleyFever]

Anyone have an opinion to share on Meta? I bought a few from $680-640. Considering averaging down.

 

[grfox92]

Not sure if it was discussed here and I missed it, but the VGT split.

Anyone have any insight as to what this will mean long term for an ETF? Its my longest hold and makes up the majority of my portfolio and has done 315% for me since I bought it way back when.

 

[Beendare]

I own Meta and yes, it has been frustrating. I wish they would’ve went the Apple route and not gone overboard on their Cap ex spending to AI which is what’s killing the stock.

META is still growing their top line with over 40% profit margin. My guess is they can earn their way out of this. That said it would not surprise me if it went below 600 in the near future close to the recent low. If it gets down near 580 I will probably buy a little bit more.

VGT great investment. Technology will continue to be more and more of our lives. VGT is very concentrated in half a dozen good stocks…..and its Vanguard

Currently I like QTEC a little bit better - core holding for me- because it’s more diversified. Compare the holdings between those two ETFs.. QTEC has right about the same performance as VGT.

 

[Baddog]

I figured sndk was about topped out around 700 in March. Now I’m debating buying some at 1400.

She’s on a run for sure

 

[KsRancher]

Not sure if it was discussed here and I missed it, but the VGT split.

Anyone have any insight as to what this will mean long term for an ETF? Its my longest hold and makes up the majority of my portfolio and has done 315% for me since I bought it way back when.

No idea on what the split will do. But I hold a decent percentage of VGT in my 401k. It has treated me pretty good

 

[Coveyleader]

AMD is making me cry!

 

[LFC911]

AMD is making me cry!

you're not the only one

 

[Coveyleader]

I sold half off, still have a bit, I'm almost ready to dive back in. NVIDIA es a dog compared to this at this point. I just watched it go from 330 to 430 in a matter of days.

 

[ganguscows]

Sure is making me happy. Only wish I had more...

 

[Coveyleader]

Sure is making me happy. Only wish I had more...

Don't we all!

 

[HuntHarder]

SMR'S up big again today.

 

[LFC911]

SMR'S up big again today.

Just when i sold it LOL but SMCI made up for it!!!

 

[Beendare]

Update to stocks I mentioned here and my take;
NVO- had announced poor sales projections in 2026 and it tanked the stock. I piled in under $40 as the valuation was cheap. They just came out with good earnings with probably more room to run though its less of a no brainer:

Novo Nordisk Raises 2026 Outlook on Strong Wegovy Pill Sales

Reported Q1 sales and operating profit surged 24% and 54%, respectively, boosted

by a $4.2B reversal of 340B Drug Pricing Program rebate provision. On an adjusted

basis (excluding this item), sales declined 10% (or -4% CER) due to lower realized

prices, particularly in the U.S., partially offset by volume growth. The Wegovy pill,

launched in January, delivered DKK2.3B in Q1 sales with weekly prescriptions

exceeding 200k by mid-April and 2M+ total prescriptions, while injectable Wegovy

grew 12% CER internationally, though U.S. sales fell 11% CER on pricing pressure.

Management raised its 2026 outlook, with adjusted sales and operating profit now

expected to decline 4%-12% CER (vs. prior -5% to -13%), reflecting stronger GLP-1

expectations, particularly for the Wegovy pill. Wegovy pill’s strong launch trajectory

is encouraging, with international rollout expected in 2H 2026. However, persistent

U.S. pricing pressure, mixed clinical data (CagriSema setbacks), and intensifying

competition warrant close monitoring.

 

[LFC911]

I DCA'd into NVO and have 535 shares at an average cost of $43.68...glad to see it's up.